Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany.
Krebs M, Haller F, Spörl S, Gerhard-Hartmann E, Utpatel K, Maurus K, Kunzmann V, Chatterjee M, Venkataramani V, Maatouk I, Bittrich M, Einwag T, Meidenbauer N, Tögel L, Hirsch D, Dietmaier W, Keil F, Scheiter A, Immel A, Heudobler D, Einhell S, Kaiser U, Sedlmeier AM, Maurer J, Schenkirsch G, Jordan F, Schmutz M, Dintner S, Rosenwald A, Hartmann A, Evert M, Märkl B, Bargou R, Mackensen A, Beckmann MW, Pukrop T, Herr W, Einsele H, Trepel M, Goebeler ME, Claus R, Kerscher A, Lüke F. Krebs M, et al. Among authors: scheiter a. Eur J Cancer. 2024 Aug;207:114144. doi: 10.1016/j.ejca.2024.114144. Epub 2024 May 31. Eur J Cancer. 2024. PMID: 38852290 Free article.
Antibodies against viral nucleo-, phospho-, and X protein contribute to serological diagnosis of fatal Borna disease virus 1 infections.
Neumann B, Angstwurm K, Linker RA, Knoll G, Eidenschink L, Rubbenstroth D, Schlottau K, Beer M, Schreiner P, Soutschek E, Böhmer MM, Lampl BMJ, Pregler M, Scheiter A, Evert K, Zoubaa S, Riemenschneider MJ, Asbach B, Gessner A, Niller HH, Schmidt B, Bauswein M. Neumann B, et al. Among authors: scheiter a. Cell Rep Med. 2022 Jan 18;3(1):100499. doi: 10.1016/j.xcrm.2021.100499. eCollection 2022 Jan 18. Cell Rep Med. 2022. PMID: 35106511 Free PMC article.
Cellular Dissociation Grading Based on the Parameters Tumor Budding and Cell Nest Size in Pretherapeutic Biopsy Specimens Allows for Prognostic Patient Stratification in Esophageal Squamous Cell Carcinoma Independent From Clinical Staging.
Jesinghaus M, Brühl F, Steiger K, Klare P, Reiser M, Scheiter A, Konukiewitz B, Kuhn P, Münch S, Quante M, Schmid RM, Wilhelm D, Feith M, Friess H, Combs SE, Saur D, Boxberg M, Weichert W. Jesinghaus M, et al. Among authors: scheiter a. Am J Surg Pathol. 2019 May;43(5):618-627. doi: 10.1097/PAS.0000000000001230. Am J Surg Pathol. 2019. PMID: 30807302
STRN-ALK Fusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy.
Gerthofer V, Scheiter A, Lüke F, Keil F, Utpatel K, Pöhmerer LM, Seitz J, Niessen C, Ignatov A, Dietmaier W, Calvisi DF, Evert M, Ortmann O, Seitz S. Gerthofer V, et al. Among authors: scheiter a. JCO Precis Oncol. 2021 Sep 16;5:PO.21.00184. doi: 10.1200/PO.21.00184. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34568722 Free PMC article. No abstract available.
RASSF1A independence and early galectin-1 upregulation in PIK3CA-induced hepatocarcinogenesis: new therapeutic venues.
Scheiter A, Evert K, Reibenspies L, Cigliano A, Annweiler K, Müller K, Pöhmerer LM, Xu H, Cui G, Itzel T, Materna-Reichelt S, Coluccio A, Honarnejad K, Teufel A, Brochhausen C, Dombrowski F, Chen X, Evert M, Calvisi DF, Utpatel K. Scheiter A, et al. Mol Oncol. 2022 Mar;16(5):1091-1118. doi: 10.1002/1878-0261.13135. Epub 2021 Nov 20. Mol Oncol. 2022. PMID: 34748271 Free PMC article.
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA Consortium.
Lüke F, Haller F, Utpatel K, Krebs M, Meidenbauer N, Scheiter A, Spoerl S, Heudobler D, Sparrer D, Kaiser U, Keil F, Schubart C, Tögel L, Einhell S, Dietmaier W, Huss R, Dintner S, Sommer S, Jordan F, Goebeler ME, Metz M, Haake D, Scheytt M, Gerhard-Hartmann E, Maurus K, Brändlein S, Rosenwald A, Hartmann A, Märkl B, Einsele H, Mackensen A, Herr W, Kunzmann V, Bargou R, Beckmann MW, Pukrop T, Trepel M, Evert M, Claus R, Kerscher A. Lüke F, et al. Among authors: scheiter a. Cancers (Basel). 2022 Oct 14;14(20):5040. doi: 10.3390/cancers14205040. Cancers (Basel). 2022. PMID: 36291825 Free PMC article.
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre.
Scheiter A, Hierl F, Lüke F, Keil F, Heudobler D, Einhell S, Klier-Richter M, Konstandin NP, Weber F, Scheiter A, Kandulski A, Schlosser S, Cosma LS, Tews H, Weiss ARR, Grube M, Bumes E, Hau P, Proescholdt M, Steger F, Troeger A, Haferkamp S, Reibenspies LE, Schnabel MJ, Schulz C, Drexler K, Hatzipanagiotou ME, Seitz S, Klinkhammer-Schalke M, Unberath P, Calvisi DF, Pukrop T, Dietmaier W, Evert M, Utpatel K. Scheiter A, et al. Br J Cancer. 2023 Apr;128(6):1134-1147. doi: 10.1038/s41416-022-02120-x. Epub 2022 Dec 26. Br J Cancer. 2023. PMID: 36572733 Free PMC article.
28 results